3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Hyperthermia
20
Sarcoma
8
Uterine Cervical Neoplasms
7
Breast Neoplasms
6
Rectal Neoplasms
5
Prostatic Neoplasms
5
Ovarian Neoplasms
5
Colonic Neoplasms
5
Neoplasm Metastasis
4
Head and Neck Neoplasms
4
Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Sarcoma, Synovial
2
Neurofibrosarcoma
2
Liver Neoplasms
2
Liposarcoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Fibrosarcoma
2
Colorectal Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Interventions
Capecitabine
20
Oxaliplatin
13
Irinotecan
8
spartalizumab
6
tislelizumab
4
Radiation
4
Immune Checkpoint Inhibitors
4
Fluorouracil
4
toripalimab
3
Neoadjuvant Therapy
3
sintilimab
2
camrelizumab
2
Radiotherapy
2
Leucovorin
2
Celecoxib
2
veliparib
1
peposertib
1
nimotuzumab
1
irinotecan sucrosofate
1
XELOX
1
Thymalfasin
1
Radiotherapy, Intensity-Modulated
1
Injections
1
HMPL-013
1
Folfox protocol
1
Diathermy
1
Combined Modality Therapy
1
Chemoradiotherapy
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Locally Advanced Rectal Cancer
×
Diathermy
×
Clear all
NCT02290574
2019-11-01
NEOTREAT
Samsung Medical Center
Phase NA
Terminated
14 enrolled
7 charts